An 81-year-old male with an implanted DDD pacemaker reported fluctuating edema accompanied by pain and paresthesia affecting the hand and arm on the side the pacemaker had been implanted. These symptoms, which developed several weeks after the procedure, were more pronounced in the morning and resolved du - ring the day. Venography showed axillary vein compression, whose severity varied with different arm positions. Changing the location of the pacemaker pocket restored normal venous blood flow at the site of compression and relieved the patient’s symptoms, which was confirmed during follow-up.
{"title":"Intermittent positional axillary vein compression – a rare complication of CIED implantation","authors":"R. Steckiewicz, P. Stolarz, E. Świętoń","doi":"10.5603/aa.2021.0012","DOIUrl":"https://doi.org/10.5603/aa.2021.0012","url":null,"abstract":"An 81-year-old male with an implanted DDD pacemaker reported fluctuating edema accompanied by pain and paresthesia affecting the hand and arm on the side the pacemaker had been implanted. These symptoms, which developed several weeks after the procedure, were more pronounced in the morning and resolved du - ring the day. Venography showed axillary vein compression, whose severity varied with different arm positions. Changing the location of the pacemaker pocket restored normal venous blood flow at the site of compression and relieved the patient’s symptoms, which was confirmed during follow-up.","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47262827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"New predictors of atherosclerosis progression after surgical interventions on the arteries of the lower extremities","authors":"R. Kalinin, I. Suchkov, E. A. Klimentova","doi":"10.5603/aa.2021.0015","DOIUrl":"https://doi.org/10.5603/aa.2021.0015","url":null,"abstract":"","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49284318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Iłżecki, M. Feldo, A. Bogucka-Kocka, D. Zalewski, Paulina Chmiel, Shawn Dave, J. Iłżecka, T. Zubilewicz
{"title":"Biomarkers of brain ischemia-reperfusion injury after carotid endarterectomy","authors":"M. Iłżecki, M. Feldo, A. Bogucka-Kocka, D. Zalewski, Paulina Chmiel, Shawn Dave, J. Iłżecka, T. Zubilewicz","doi":"10.5603/aa.2021.0013","DOIUrl":"https://doi.org/10.5603/aa.2021.0013","url":null,"abstract":"","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48440624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Dybowska, D. Dybowski, M. Szturmowicz, K. Lewandowska, M. Sobiecka, D. Wyrostkiewicz, W. Tomkowski
For two years, the entire world has been grappling with the new challenge that is the COVID-19 pandemic. In December 2019 in China's largest province, Wuhan, Severe Acute Respiratory Syndrome- Coronavirus-2 (SARS-CoV-2), was detected in a patient with severe respiratory failure. Shortly after, infections were detected in all regions of the world. So far, 265 million infections have been confirmed around the world, and 5.2 million of those infected have died due to COVID-19. Infection with SARS-CoV-2 is associated with an increased risk of cardiovascular complications, especially thromboembolic complications. Low-molecular-weight-heparin presents a basic form of prophylaxis against thromboembolic complications in individuals who are ill with COVID-19. Controversy still exists regarding the optimal dose of LMWH depending on disease severity, this problem requires further randomized trials.
{"title":"Thromboprophylaxis in patients with Covid-19","authors":"M. Dybowska, D. Dybowski, M. Szturmowicz, K. Lewandowska, M. Sobiecka, D. Wyrostkiewicz, W. Tomkowski","doi":"10.5603/aa.2021.0016","DOIUrl":"https://doi.org/10.5603/aa.2021.0016","url":null,"abstract":"For two years, the entire world has been grappling with the new challenge that is the COVID-19 pandemic. In December 2019 in China's largest province, Wuhan, Severe Acute Respiratory Syndrome- Coronavirus-2 (SARS-CoV-2), was detected in a patient with severe respiratory failure. Shortly after, infections were detected in all regions of the world. So far, 265 million infections have been confirmed around the world, and 5.2 million of those infected have died due to COVID-19. Infection with SARS-CoV-2 is associated with an increased risk of cardiovascular complications, especially thromboembolic complications. Low-molecular-weight-heparin presents a basic form of prophylaxis against thromboembolic complications in individuals who are ill with COVID-19. Controversy still exists regarding the optimal dose of LMWH depending on disease severity, this problem requires further randomized trials.","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49046018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Z. Krasiński, Tomasz Urbanek, A. Undas, Joanna Rupa-Matysek, A. Araszkiewicz, K. Derwich, Aneta Klotzka, Artur A. Antoniewicz, Beata Begier-Krasińska, Cezary Piwkowski, T. Banasiewicz, Marcin Gabriel, Piotr Ładziński, W. Tomkowski, D. Murawa, R. Ramlau, P. Rutkowski, Piotr Pruszczyk, F. Szymański, Andrzej Szuba, Tomasz Zubilewicz, Stefan Sajdak, J. Windyga
{"title":"Wytyczne leczenia i profilaktyki żylnej choroby zatorowo-zakrzepowej u chorych onkologicznych leczonych operacyjnie z uwzględnieniem chorych poniżej 18. roku życia","authors":"Z. Krasiński, Tomasz Urbanek, A. Undas, Joanna Rupa-Matysek, A. Araszkiewicz, K. Derwich, Aneta Klotzka, Artur A. Antoniewicz, Beata Begier-Krasińska, Cezary Piwkowski, T. Banasiewicz, Marcin Gabriel, Piotr Ładziński, W. Tomkowski, D. Murawa, R. Ramlau, P. Rutkowski, Piotr Pruszczyk, F. Szymański, Andrzej Szuba, Tomasz Zubilewicz, Stefan Sajdak, J. Windyga","doi":"10.5603/aa.2021.0006","DOIUrl":"https://doi.org/10.5603/aa.2021.0006","url":null,"abstract":"","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41638803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Endovascular techniques have revolutionized the treatment of lower extremity artery disease (LEAD). Despite this, the treatment of complex femoropopliteal lesions is a field of debate. This report sum marizes the current experience in the treatment of complex femoropopliteal lesions in the author’s center. Material and methods: This is a retrospective, observational cohort study of patients with complex (TASC C and D) femoropopliteal lesions. The patients were treated using either endovascular procedure or surgical bypass. Details of the procedure, complications, mortality and amputation rate, primary and secondary patency rates, and reinterventions were analyzed. Results: The study included 201 patients. One hundred thirty patients received endovascular treatment (ET), whereas in 67 a femoropopliteal bypass (FB) was implanted. The hybrid approach was utilized in 4 patients. ET was preferred in primary (88.5% vs. 47.8%, p < 0.001), shorter (25 vs. 30 cm, p < 0.02), TASC C lesions (63.1% vs. 40.3%, p < 0.003). Complications were more common in FB group (26.9% vs. 13.8%, p < 0.03). Reinterventions were similar. The postoperative stay was shorter in the ET group (1 vs. 6 days, p < 0.001). Primary and secondary patency rates for autologous vein reconstruction were insignificantly higher than for ET. Primary and secondary patency in patients with synthetic bypass was significantly inferior to autologous vein conduit (AVC) and endovascular procedure. The limb salvage at 3 years was highest in the ET group (94.1%) and the difference was significant (p < 0.04, and p < 0.001 for AVC and synthetic bypass, respectively). Conclusions: ET is preferred in primary and shorter lesions and is related to the shorter postoperative stay. It carries a lower risk of major amputation than surgery. Autologous vein conduit provides highest primary and secondary patency rates. Both treatment options (surgery and endovascular) should be considered in patients with long femoropopliteal lesions to assure the optimal outcome.
血管内技术已经彻底改变了下肢动脉疾病(LEAD)的治疗。尽管如此，复杂股腘病变的治疗仍是一个有争议的领域。本报告总结了目前在作者中心治疗复杂股腘病变的经验。材料和方法:这是一项针对复杂(TASC C和D)股腘动脉病变患者的回顾性观察队列研究。患者采用血管内手术或旁路手术治疗。分析手术细节、并发症、死亡率和截肢率、原发性和继发性通畅率以及再干预。结果:纳入201例患者。130例患者接受了血管内治疗(ET)， 67例患者接受了股腘动脉搭桥(FB)。4例患者采用混合入路。ET优先用于原发性(88.5%对47.8%，p < 0.001)、较短(25对30 cm, p < 0.02)、TASC C病变(63.1%对40.3%，p < 0.003)。FB组并发症发生率较高(26.9% vs 13.8%， p < 0.03)。再干预情况相似。ET组术后住院时间较短(1天vs. 6天，p < 0.001)。自体静脉重建的原发性和继发性通畅率不显著高于ET。人工搭桥患者的原发性和继发性通畅率明显低于自体静脉导管(AVC)和血管内手术。ET组3年肢体保留率最高(94.1%)，AVC组和人工旁路组差异有统计学意义(p < 0.04, p < 0.001)。结论:ET优先用于原发性和较短的病变，并与较短的术后住院时间有关。它比手术有更低的截肢风险。自体静脉导管提供最高的原发性和继发性通畅率。长股腘病变患者应考虑两种治疗方案(手术和血管内)，以确保最佳结果。
{"title":"The treatment of complex femoropopliteal atherosclerotic lesions- conclusions from the unselected patients cohort.","authors":"Aleksander Łukasiewicz","doi":"10.5603/aa.2021.0011","DOIUrl":"https://doi.org/10.5603/aa.2021.0011","url":null,"abstract":"Introduction: Endovascular techniques have revolutionized the treatment of lower extremity artery disease (LEAD). Despite this, the treatment of complex femoropopliteal lesions is a field of debate. This report sum marizes the current experience in the treatment of complex femoropopliteal lesions in the author’s center. Material and methods: This is a retrospective, observational cohort study of patients with complex (TASC C and D) femoropopliteal lesions. The patients were treated using either endovascular procedure or surgical bypass. Details of the procedure, complications, mortality and amputation rate, primary and secondary patency rates, and reinterventions were analyzed. Results: The study included 201 patients. One hundred thirty patients received endovascular treatment (ET), whereas in 67 a femoropopliteal bypass (FB) was implanted. The hybrid approach was utilized in 4 patients. ET was preferred in primary (88.5% vs. 47.8%, p < 0.001), shorter (25 vs. 30 cm, p < 0.02), TASC C lesions (63.1% vs. 40.3%, p < 0.003). Complications were more common in FB group (26.9% vs. 13.8%, p < 0.03). Reinterventions were similar. The postoperative stay was shorter in the ET group (1 vs. 6 days, p < 0.001). Primary and secondary patency rates for autologous vein reconstruction were insignificantly higher than for ET. Primary and secondary patency in patients with synthetic bypass was significantly inferior to autologous vein conduit (AVC) and endovascular procedure. The limb salvage at 3 years was highest in the ET group (94.1%) and the difference was significant (p < 0.04, and p < 0.001 for AVC and synthetic bypass, respectively). Conclusions: ET is preferred in primary and shorter lesions and is related to the shorter postoperative stay. It carries a lower risk of major amputation than surgery. Autologous vein conduit provides highest primary and secondary patency rates. Both treatment options (surgery and endovascular) should be considered in patients with long femoropopliteal lesions to assure the optimal outcome.","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44759434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Komentarz do wytycznych postępowania w przypadku przewlekłych schorzeń żylnych kończyn dolnych ― „Zapobieganie zespołowi pozakrzepowemu” pod redakcją Andrew Nicolaidesa i wsp.","authors":"Z. Krasiński, Andrzej Jawień","doi":"10.5603/aa.2021.0007","DOIUrl":"https://doi.org/10.5603/aa.2021.0007","url":null,"abstract":"","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43020674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michał Terpiłowski, M. Iłżecki, S. Przywara, Barbara Terpiłowska, P. Terlecki, T. Zubilewicz
Endovascular aneurysm repair (EVAR) is a widely accepted alternative for open surgical repair (OSR) in the treatment of an abdominal aortic aneurysm (AAA). Meta-analyses of randomized controlled trials revealed significantly lower short-term mortality after EVAR procedure than OSR. From a technical point of view, proper sizing and selection of the stent-graft is very important. Most instructions for use (IFUs) of the current endo grafts recommend 10–20% oversizing concerning the preoperative aortic diameter. It can prevent endoleaks or subsequent complications such as displacement of the leg to the abdominal aneurysmal sac. In this paper, we present a case of a 64-year-old male with a history of abdominal aortic aneurysm with concomitant common iliac artery (CIA) aneurysm. The patient underwent endovascular implantation of bifurcated stent-graft with extension to the right common iliac artery. He was admitted to the Department of Vascular Surgery due to increasing pain in the right-lower abdomen. The analysis of the imaging examination and the symptoms of an increasing lower limb ischaemia caused by deformation of the stent-graft allowed deciding for an endovascular intervention involving the implantation of the iliac side branch device (IBD). Postoperative angiography confir med the correct location of the IBD with proper blood flow. After five days the patient was discharged home.
{"title":"Postoperative endoleak after EVAR and effective endovascular reintervention. The case of the 64-year old male with abdominal aortic aneurysm with concomitant common iliac artery aneurysm.","authors":"Michał Terpiłowski, M. Iłżecki, S. Przywara, Barbara Terpiłowska, P. Terlecki, T. Zubilewicz","doi":"10.5603/aa.2021.0010","DOIUrl":"https://doi.org/10.5603/aa.2021.0010","url":null,"abstract":"Endovascular aneurysm repair (EVAR) is a widely accepted alternative for open surgical repair (OSR) in the treatment of an abdominal aortic aneurysm (AAA). Meta-analyses of randomized controlled trials revealed significantly lower short-term mortality after EVAR procedure than OSR. From a technical point of view, proper sizing and selection of the stent-graft is very important. Most instructions for use (IFUs) of the current endo grafts recommend 10–20% oversizing concerning the preoperative aortic diameter. It can prevent endoleaks or subsequent complications such as displacement of the leg to the abdominal aneurysmal sac. In this paper, we present a case of a 64-year-old male with a history of abdominal aortic aneurysm with concomitant common iliac artery (CIA) aneurysm. The patient underwent endovascular implantation of bifurcated stent-graft with extension to the right common iliac artery. He was admitted to the Department of Vascular Surgery due to increasing pain in the right-lower abdomen. The analysis of the imaging examination and the symptoms of an increasing lower limb ischaemia caused by deformation of the stent-graft allowed deciding for an endovascular intervention involving the implantation of the iliac side branch device (IBD). Postoperative angiography confir med the correct location of the IBD with proper blood flow. After five days the patient was discharged home.","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45664191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Iłżecki, M. Feldo, A. Bogucka-Kocka, D. Zalewski, Paulina Chmiel, Shavn Dave, J. Iłżecka
Introduction: Endarterectomy of the internal carotid artery (CEA) plays an important role in the prevention of cerebral ischemic stroke; however, this surgical procedure may cause neurological complications. The aim of this study was to evaluate changes in serum levels of the oxidative stress marker peroxiredoxin-1 (PRDX1) in patients undergoing CEA. Material and methods: Twenty-four patients undergoing endarterectomy for critical stenosis of the internal carotid artery participated in the study. Blood for testing was collected before CEA and twice after surgery. PRDX1 was determined by ELISA. Results: The timing of blood sampling did not affect PRDX1 levels (p > 0.05). There was no statistically significant difference in serum PRDX1 levels between male and female groups and depending on the age of the patients (p > 0.05). Conclusion: PRDX1 cannot be considered as a marker of neurological complications after CEA.
{"title":"Serum peroxiredoxin-1 in patients undergoing carotid endarterectomy – short report","authors":"M. Iłżecki, M. Feldo, A. Bogucka-Kocka, D. Zalewski, Paulina Chmiel, Shavn Dave, J. Iłżecka","doi":"10.5603/aa.2021.0009","DOIUrl":"https://doi.org/10.5603/aa.2021.0009","url":null,"abstract":"Introduction: Endarterectomy of the internal carotid artery (CEA) plays an important role in the prevention of cerebral ischemic stroke; however, this surgical procedure may cause neurological complications. The aim of this study was to evaluate changes in serum levels of the oxidative stress marker peroxiredoxin-1 (PRDX1) in patients undergoing CEA. Material and methods: Twenty-four patients undergoing endarterectomy for critical stenosis of the internal carotid artery participated in the study. Blood for testing was collected before CEA and twice after surgery. PRDX1 was determined by ELISA. Results: The timing of blood sampling did not affect PRDX1 levels (p > 0.05). There was no statistically significant difference in serum PRDX1 levels between male and female groups and depending on the age of the patients (p > 0.05). Conclusion: PRDX1 cannot be considered as a marker of neurological complications after CEA.","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47195369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Head and neck lymphedema (HNL) – a review paper.","authors":"Karolina Dorobisz, A. Szuba, T. Zatoński","doi":"10.5603/aa.2021.0008","DOIUrl":"https://doi.org/10.5603/aa.2021.0008","url":null,"abstract":"","PeriodicalId":41754,"journal":{"name":"Acta Angiologica","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44631458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：